FDA-approved epilepsy drug may help reverse osteoarthritis damage
Researchers at Yale have identified a promising new approach to osteoarthritis that could do more than simply ease pain. The epilepsy drug lacosamide appears to block a protein involved in both pain signaling and cartilage destruction, helping damaged joints shift back toward repair in preclinical studies.
We haven't written up this one. ScienceDaily has the full story — the link below goes straight to it.
This story
This is one outlet's version. Read the fullest account.
- FDA-approved epilepsy drug may help reverse osteoarthritis damage sciencedaily.com
